Formyl-peptide receptors revisited

被引:518
作者
Le, YY
Murphy, PM
Wang, JM
机构
[1] NCI, CCR, LMI, Frederick, MD 21702 USA
[2] NIAID, Lab Host Def, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1016/S1471-4906(02)02316-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Leukocytes accumulate at sites of inflammation and microbial infection in direct response to locally produced chemotactic factors, which signal through specific G protein-coupled receptors. The first chemotactic factors to be structurally defined were the N-formyl peptides. Unlike other leukocyte chemoattractants, N-formyl peptides could originate from either an endogenous source, such as the mitochondrial proteins of ruptured host cells, or an exogenous source, such as the proteins of invading pathogens. This suggests that the formyl-peptide receptor (FPR) and its variant FPRL1 (FPR-like 1) are involved in host defense against bacterial infection and in the clearance of damaged cells. Recently, additional, more complex, roles for these receptors have been proposed because FPR, and to a greater extent FPRL1, have been found to interact with a menagerie of structurally diverse pro- and anti-inflammatory ligands associated with different diseases, including amyloidosis, Alzheimer's disease, prion disease and HIV How these receptors recognize such diverse ligands, which are the most important in vivo, and how they contribute to disease pathogenesis and host defense are basic questions currently under investigation that could lead to new therapeutic targets.
引用
收藏
页码:541 / 548
页数:8
相关论文
共 65 条
[1]   Inflammation and Alzheimer's disease [J].
Akiyama, H ;
Barger, S ;
Barnum, S ;
Bradt, B ;
Bauer, J ;
Cole, GM ;
Cooper, NR ;
Eikelenboom, P ;
Emmerling, M ;
Fiebich, BL ;
Finch, CE ;
Frautschy, S ;
Griffin, WST ;
Hampel, H ;
Hull, M ;
Landreth, G ;
Lue, LF ;
Mrak, R ;
Mackenzie, IR ;
McGeer, PL ;
O'Banion, MK ;
Pachter, J ;
Pasinetti, G ;
Plata-Salaman, C ;
Rogers, J ;
Rydel, R ;
Shen, Y ;
Streit, W ;
Strohmeyer, R ;
Tooyoma, I ;
Van Muiswinkel, FL ;
Veerhuis, R ;
Walker, D ;
Webster, S ;
Wegrzyniak, B ;
Wenk, G ;
Wyss-Coray, T .
NEUROBIOLOGY OF AGING, 2000, 21 (03) :383-421
[2]   Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity [J].
Aliberti, J ;
Hieny, S ;
Sousa, CRE ;
Serhan, CN ;
Sher, A .
NATURE IMMUNOLOGY, 2002, 3 (01) :76-82
[3]  
BAO L, 1992, Genomics, V13, P437, DOI 10.1016/0888-7543(92)90265-T
[4]   A proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosis [J].
Betten, Å ;
Bylund, J ;
Cristophe, T ;
Boulay, F ;
Romero, A ;
Hellstrand, K ;
Dahlgren, C .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (08) :1221-1228
[5]   SYNTHESIS AND USE OF A NOVEL N-FORMYL PEPTIDE DERIVATIVE TO ISOLATE A HUMAN N-FORMYL PEPTIDE RECEPTOR CDNA [J].
BOULAY, F ;
TARDIF, M ;
BROUCHON, L ;
VIGNAIS, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 168 (03) :1103-1109
[6]   THE HUMAN N-FORMYLPEPTIDE RECEPTOR - CHARACTERIZATION OF 2 CDNA ISOLATES AND EVIDENCE FOR A NEW SUBFAMILY OF G-PROTEIN-COUPLED RECEPTORS [J].
BOULAY, F ;
TARDIF, M ;
BROUCHON, L ;
VIGNAIS, P .
BIOCHEMISTRY, 1990, 29 (50) :11123-11133
[7]  
BOYLE MDP, 1987, J IMMUNOL, V139, P169
[8]   Activation of the formyl peptide receptor by the HIV-derived peptide T-20 suppresses interleukin-12 p70 production by human monocytes [J].
Braun, MC ;
Wang, JM ;
Lahey, E ;
Rabin, RL ;
Kelsall, BL .
BLOOD, 2001, 97 (11) :3531-3536
[9]  
Brown DR, 1997, HISTOL HISTOPATHOL, V12, P883
[10]   MITOCHONDRIAL N-FORMYLMETHIONYL PROTEINS AS CHEMOATTRACTANTS FOR NEUTROPHILS [J].
CARP, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (01) :264-275